Search Tag: dalteparin

2018 13 Jun

There is concern about excessive bleeding when low-molecular-weight heparins (LMWHs) are used for venous thromboembolism (VTE) prophylaxis in renal dysfunction. To evaluate whether LMWH VTE prophylaxis was safe and effective in critically ill patients with renal dysfunction, researchers conducted a subgroup analysis of PROTECT, a randomised trial...Read more

2014 01 Nov

According to a study published in JAMA, prevention of venous thromboembolism (VTE) with low-molecular-weight heparin (LMWH) dalteparin in critically ill patients was more effective and had similar or lower costs  compared to unfractionated heparin (UFH). The study is to be presented at the Critical Care Canada Forum. The PROTECT trial compared the...Read more